Wearable technology can tell when you’re going to get ill

A new study has found that wearable technology can be used to tell if someone is falling ill (New Scientist, 2017). Stanford University geneticist Michael Snyder wore eight fitness tracking devices every day for two years to see if there were any differences between them (Scientific American, 2017). He and several colleagues also put the … Continue reading Wearable technology can tell when you’re going to get ill

Statins may reduce the risk of blood clots in the vein

A study published by Dr Setor Kunutsor of the Musculoskeletal Research Unit in the University of Bristol’s School of Clinical Sciences, with colleagues from the University of Leicester, has confirmed that statins could play an important role in reducing the risk of venous thromboembolism (University of Bristol, 2017). Statins are groups of medications that reduce … Continue reading Statins may reduce the risk of blood clots in the vein

Heart attack risk in rheumatoid arthritis patients almost halved by biologic drugs

A biologic drug which treats rheumatoid arthritis has been shown to reduce the risk of heart attacks in arthritis patients by up to 40% (University of Manchester, 2017). Patients with rheumatoid arthritis have a 60% higher risk of heart attacks than the general public, which is thought to be linked to the inflammation caused by … Continue reading Heart attack risk in rheumatoid arthritis patients almost halved by biologic drugs

New research on how bacteria resists last-resort antibiotic

A team of University of Bristol-led researchers has provided the first clues to understand how the mcr-1 gene protects bacteria from colistin, a last resort antibiotic used to treat life-threatening bacterial infections that do not respond to other treatment options (University of Bristol, 2017). Last year, members of the team, led by Dr Jim Spencer … Continue reading New research on how bacteria resists last-resort antibiotic

Aberystwyth University submits planning application for new Innovation Campus

A planning application has been submitted for a new £40.5m Innovation and Enterprise Campus at Aberystwyth University (WalesOnline, 2017). Based on the University’s Gogerddan campus, the Aberystwyth Innovation and Enterprise Campus (AIEC) development will feature a bio-refining centre, future food centre, analytical science laboratories and a seed processing and biobank facility. The campus is planned … Continue reading Aberystwyth University submits planning application for new Innovation Campus

Swansea University study looking at delaying the onset of dementia

Dr Claire Hanley, a psychologist from Swansea University’s College of Human and Health Sciences is recruiting for a study using transcranial direct current stimulation, a technology which could ultimately delay the onset of dementia (Swansea University, 2017). Dementia costs £1.4bn per year in Wales. Dr Hanley specialises in cognitive neuroscience, specifically what happens to the … Continue reading Swansea University study looking at delaying the onset of dementia

Welsh researchers have made a major breakthrough in diagnosing bowel cancer

A simple blood test developed by Welsh experts could lead to bowel cancer patients being diagnosed much earlier and significantly improve their chances of survival (WalesOnline, 2016). Initial signs are so promising the test could become used throughout the NHS within the next few years, with a clinical trial starting in GP practices across Abertawe … Continue reading Welsh researchers have made a major breakthrough in diagnosing bowel cancer

Manchester Molecular Pathology Innovation Centre announces strategic collaboration with Singulex

The University of Manchester has announced a strategic collaboration with US company Singulex, a leader in the use of single molecule counting technology as a diagnostic tool (The University of Manchester, 2016). Singulex has installed its SMCTM powered Sgx ClarityTM System in the Manchester Molecular Pathology Innovation Centre (MMPathIC) labs as part of its ongoing … Continue reading Manchester Molecular Pathology Innovation Centre announces strategic collaboration with Singulex

Genetics links sleep disturbance with restless leg syndrome, schizophrenia and obesity

A team of American and British scientists have discovered genetic connections between sleep disturbance and a range of medical disorders including obesity (The University of Manchester, 2016). Lead author Dr Jacqueline Lane, postdoctoral fellow at Massachusetts General Hospital (MGH) and joint senior authors Richa Saxena, Assistant Professor of Anaesthesia at the MGH and Harvard Medical … Continue reading Genetics links sleep disturbance with restless leg syndrome, schizophrenia and obesity

Laser treatment prostate cancer is a potential game changer

Scientists at University College London have made what they believe is a real breakthrough for prostate cancer, long seen as the Cinderella of cancers, using a drug derived from bacteria found at the bottom of the sea, injected into the bloodstream and activated in the prostate by laser beams (The Guardian, 2016). The treatment has … Continue reading Laser treatment prostate cancer is a potential game changer

Free WordPress Themes, Free Android Games